SINAInnovations 2016: Panel Discussion - Novel Approaches to Drug Screening

Day Two Panel Discussion – Novel Approaches to Drug Screening Moderator: Robert J. DeVita, PhD, Director of Medicinal Chemistry, Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai Panelists: •Michelle Arkin, PhD, Associate Professor, Pharmaceutical Chemistry; Director of Biology, Small Molecule Discovery Center, University of California San Francisco •Michael A. Foley, PhD, Sanders Director, Tri-Institutional Therapeutics Discovery Institute •Geraldine A. Hamilton, PhD, President and Chief Scientific Officer, Emulate Inc. •Peter Hodder, PhD, Executive Director, Discovery Technologies, Amgen •David Israel, PhD, Director, Cell and Molecular Technologies, GlaxoSmithKline Introduction by Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, Icahn School of Medicine at Mount Sinai.